We are live on !
Find out more
Creative Planning Portfolio holdings
AUM
$171B
Turnover
10.62%
1-Year Est. Return
24.68%
This Fund
S&P 500
This Quarter Est. Return
+14.14%
1 Year Est. Return
+24.68%
3 Year Est. Return
+62.17%
5 Year Est. Return
+55.89%
10 Year Est. Return
+171.9%
AUM
$171B
AUM Growth
+$23.7B
(+16%)
Cap. Flow
+$6.93B
Cap. Flow % of AUM
Cap. Flow %
4.05%
Top 10 Holdings %
Top 10 Hldgs %
41.66%
Holding
4,427
New
337
Increased
2,605
Reduced
1,239
Closed
133
Avg Time Held
Equity + Options
4.2
years
Top 10 Avg Time Held
Equity + Options
1.7
years
Top 20 Avg Time Held
Equity + Options
4.3
years
Avg Time Held Equity only
4.3
years
Top 10 Avg Time Held Equity only
1.7
years
Top 20 Avg Time Held Equity only
4.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$682M |
| 2 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$526M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$504M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$431M |
| 5 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$239M |
| 2 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$74.4M |
| 3 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$41.1M |
| 4 |
Honeywell
HON
|
+$39.3M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$38.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 73.8% |
| 2 | Technology | 9.57% |
| 3 | Financials | 3.79% |
| 4 | Industrials | 2.49% |
| 5 | Healthcare | 2.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3301
Ezcorp Inc
EZPW
$1.79B
| $435K | ﹤0.01% |
12,592
-154
| -1% | -$4.86K |
2025 Q1
5 quarters
|
|
3302
Taysha Gene Therapies
TSHA
$1.36B
| $434K | ﹤0.01% |
63,781
+3,980
| +7% | +$23.6K |
2024 Q3
7 quarters
|
|
3303
Invesco S&P MidCap Low Volatility ETF
XMLV
$715M
| $433K | ﹤0.01% |
6,529
+645
| +11% | +$42K |
2018 Q4
30 quarters
|
|
3304
Eos Energy Enterprises
EOSE
$659M
| $432K | ﹤0.01% |
73,474
+31,022
| +73% | +$216K |
2025 Q3
3 quarters
|
|
3305
DELISTED
Esperion Therapeutics
ESPR
| $428K | ﹤0.01% |
135,487
+41,995
| +45% | +$117K |
2025 Q3
3 quarters
|
|
3306
iShares iBonds Dec 2033 Term Corporate ETF
IBDY
$1.19B
| $427K | ﹤0.01% |
16,575
-234
| -1% | -$6.03K |
2026 Q1
1 quarter
|
|
3307
KFA Mount Lucas Managed Futures Index Strategy ETF
KMLM
$595M
| $425K | ﹤0.01% |
+15,453
| New | +$443K |
2026 Q2
0 quarters
|
|
3308
State Street SPDR S&P Kensho Clean Power ETF
CNRG
$160M
| $424K | ﹤0.01% |
3,753
+749
| +25% | +$79.9K |
2025 Q3
3 quarters
|
|
3309
Defiance AI & Power Infrastructure ETF
AIPO
$784M
| $424K | ﹤0.01% |
+12,681
| New | +$394K |
2026 Q2
0 quarters
|
|
3310
Dimensional Global Sustainability Fixed Income ETF
DFSB
$758M
| $423K | ﹤0.01% |
8,119
+2,129
| +36% | +$111K |
2025 Q2
4 quarters
|
|
3311
Butterfly Network
BFLY
$1.91B
| $423K | ﹤0.01% |
50,233
+892
| +2% | +$4.62K |
2022 Q2
16 quarters
|
|
3312
Costamare
CMRE
$1.72B
| $422K | ﹤0.01% |
30,100
-4,723
| -14% | -$77.5K |
2023 Q1
13 quarters
|
|
3313
Sabine Royalty Trust
SBR
$1.06B
| $421K | ﹤0.01% |
5,756
-12,078
| -68% | -$910K |
2013 Q2
52 quarters
|
|
3314
iShares iBonds Dec 2035 Term Corporate ETF
IBCA
$408M
| $421K | ﹤0.01% |
16,451
+976
| +6% | +$25K |
2026 Q1
1 quarter
|
|
3315
ClearPoint Neuro
CLPT
$290M
| $421K | ﹤0.01% |
+23,584
| New | +$295K |
2026 Q2
0 quarters
|
|
3316
Ameresco
AMRC
$1.05B
| $420K | ﹤0.01% |
15,214
+3,038
| +25% | +$87.8K |
2025 Q2
4 quarters
|
|
3317
Myriad Genetics
MYGN
$602M
| $420K | ﹤0.01% |
73,505
+3,264
| +5% | +$14.8K |
2024 Q2
8 quarters
|
|
3318
Algonquin Power & Utilities
AQN
$4.14B
| $420K | ﹤0.01% |
71,608
+629
| +0.9% | +$3.82K |
2023 Q1
13 quarters
|
|
3319
BNY Mellon US Large Cap Core Equity ETF
BKLC
$6.9B
| $419K | ﹤0.01% |
+8,775
| New | +$406K |
2026 Q2
0 quarters
|
|
3320
Pershing Square USA
PSUS
| $419K | ﹤0.01% |
+11,219
| New | +$448K |
2026 Q2
0 quarters
|
|
3321
ALPS O'Shares U.S. Quality Dividend ETF
OUSA
$729M
| $419K | ﹤0.01% |
7,183
-90
| -1% | -$5.2K |
2023 Q2
12 quarters
|
|
3322
Capri Holdings
CPRI
$1.75B
| $419K | ﹤0.01% |
22,557
+9,174
| +69% | +$176K |
2025 Q3
3 quarters
|
|
3323
AudioEye
AEYE
$126M
| $419K | ﹤0.01% |
72,078
+1,346
| +2% | +$9.36K |
2020 Q4
22 quarters
|
|
3324
JOYY Inc
JOYY
$3.93B
| $418K | ﹤0.01% |
6,338
-631
| -9% | -$39.2K |
2024 Q3
7 quarters
|
|
3325
Eaton Vance Tax-Advantaged Global Dividend Income Fund
ETG
$1.75B
| $418K | ﹤0.01% |
17,767
+734
| +4% | +$16.5K |
2025 Q4
2 quarters
|
|
Similar funds
Creative Planning's Q2 2026 Portfolio in Review
As of Q2 2026, Creative Planning held 4,427 positions worth $171B, up 16% from $147B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Creative Planning deployed $6.93B of net new capital in Q2 2026, opening 337 new positions and adding to 2,605 existing holdings. Its largest new stake was Honeywell Aerospace: 169,880 shares worth $37.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 74% of assets, down from 76% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $239M trimmed.
- Creative Planning's largest Q2 2026 buy was Honeywell Aerospace: 169,880 shares worth $37.6M.
- Creative Planning added most to Vanguard Total Bond Market in Q2 2026, an estimated $682M increase.
- Creative Planning's biggest Q2 2026 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $239M.
- Creative Planning fully exited Hologic in Q2 2026, selling an estimated $8.29M.
- Creative Planning's ten largest holdings make up 42% of its $171B portfolio in Q2 2026.
- Creative Planning opened 337 new positions and closed 133 in Q2 2026.
- Creative Planning's portfolio value rose 16% quarter-over-quarter to $171B.
Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.